CA Patent

CA2710205C — An improved process to prepare treprostinil, the active ingredient in remodulin

Assigned to United Therapeutics Corp · Expires 2016-04-26 · 10y expired

What this patent protects

The application relates to a process for producing prostacyclin derivatives and novel intermediate compounds useful in the process. The present invention provides in one embodiment a process for the preparation of a compound of formula I, hydrate, solvate, prodrug, or pharmaceuti…

USPTO Abstract

The application relates to a process for producing prostacyclin derivatives and novel intermediate compounds useful in the process. The present invention provides in one embodiment a process for the preparation of a compound of formula I, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof. (see formula I)

Drugs covered by this patent

Patent Metadata

Patent number
CA2710205C
Jurisdiction
CA
Classification
—
Expires
2016-04-26
Drug substance claim
No
Drug product claim
No
Assignee
United Therapeutics Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.